The effect of intestinal alkaline phosphatase on intestinal epithelial cells, macrophages and chronic colitis in mice

Life Sciences

Volumn 100, Issue 2, 2014, Pages 118-124

  Lee, Changhyun ^a,b   Chun, Jaeyoung ^b   Hwang, Sung Wook ^b   Kang, Seung Joo ^a,b   Im, Jong Pil ^b   Kim, Joo Sung ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Colitis; IL 10 deficient mice; Inflammatory bowel disease; Intestinal alkaline phosphatase; Lipopolysaccharide

Indexed keywords

ALKALINE PHOSPHATASE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; INTESTINE ENZYME; LIPOPOLYSACCHARIDE; PIROXICAM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CHRONIC COLITIS; COLITIS; COLON MUCOSA; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA BINDING; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VIVO STUDY; INTESTINE EPITHELIUM CELL; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE;

MURINAE; MUS;

COLITIS; IL-10 DEFICIENT MICE; INFLAMMATORY BOWEL DISEASE; INTESTINAL ALKALINE PHOSPHATASE; KEYWORDS; LIPOPOLYSACCHARIDE;

ALKALINE PHOSPHATASE; ANIMALS; BLOTTING, WESTERN; CATTLE; CELL PROLIFERATION; CELLS, CULTURED; CHRONIC DISEASE; COLITIS; COLONIC NEOPLASMS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; I-KAPPA B PROTEINS; INTERLEUKIN-10; INTERLEUKIN-8; INTESTINES; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84897062831     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.02.003     Document Type: Article

References (41)

1. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009;361:2066-78.
2. Alpers DH, Zhang Y, Ahnen DJ. Synthesis and parallel secretion of rat intestinal alkaline phosphatase and a surfactant-like particle protein. Am J Physiol 1995;268:E1205-14.
3. Atreya I, Atreya R, Neurath MF. NF-kappaB in inflammatory bowel disease. J Intern Med 2008;263:591-6.
4. Bates JM, Akerlund J, Mittge E, Guillemin K. Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe 2007;2:371-82. (Pubitemid 350215326)
5. Berg DJ, Zhang J, Weinstock JV, Ismail HF, Earle KA, Alila H, et al. Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology 2002;123:1527-42. (Pubitemid 35231653)
6. Bol-Schoenmakers M, Fiechter D, Raaben W, Hassing I, Bleumink R, Kruijswijk D, et al. Intestinal alkaline phosphatase contributes to the reduction of severe intestinal epithelial damage. Eur J Pharmacol 2010;633:71-7.
7. Chaudhry A, Samstein RM, Treuting P, Liang Y, Pils MC, Heinrich JM, et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 2011;34:566-78.
8. Chen KT, Malo MS, Beasley-Topliffe LK, Poelstra K, Millan JL, Mostafa G, et al. A role for intestinal alkaline phosphatase in the maintenance of local gut immunity. Dig Dis Sci 2011;56:1020-7.
9. Cheon JH, Kim JS, Kim JM, Kim N, Jung HC, Song IS. Plant sterol guggulsterone inhibits nuclear factor-kappaB signaling in intestinal epithelial cells by blocking IkappaB kinase and ameliorates acute murine colitis. Inflamm Bowel Dis 2006;12:1152-61. (Pubitemid 44847473)
10. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993;178:1041-8. (Pubitemid 23260442)
11. Dixit V, Mak TW. NF-kappaB signaling. Many roads lead to Madrid. Cell 2002;111:615-9. (Pubitemid 35441244)
12. Geddes K, Philpott DJ. A new role for intestinal alkaline phosphatase in gut barrier maintenance. Gastroenterology 2008;135:8-12. (Pubitemid 351899043)
13. Goldberg RF, Austen WG, Zhang X, Munene G, Mostafa G, Biswas S, et al. Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition. Proc Natl Acad Sci 2008;105:3551-6. (Pubitemid 351723590)
14. Jobin C, Haskill S, Mayer L, Panja A, Sartor RB. Evidence for altered regulation of I kappa B alpha degradation in human colonic epithelial cells. J Immunol 1997;158:226-34. (Pubitemid 127483860)
15. Kaliannan K, Hamarneh SR, Economopoulos KP, Nasrin Alam S, Moaven O, Patel P, et al. Intestinal alkaline phosphatase prevents metabolic syndrome in mice. Proc Natl Acad Sci 2013;110:7003-8.
16. Kang SJ, Kim JM, Koh SJ, Kim SH, Im JP, Jung HC, et al. The guggulsterone derivative GG-52 inhibits NF-kappaB signaling in bone marrow-derived dendritic cells and attenuates colitis in IL-10 knockout mice. Life Sci 2013;92:1064-71.
17. Kats S, Brands R, Seinen W, de Jager W, Bekker MW, Hamad MA, et al. Anti-inflammatory effects of alkaline phosphatase in coronary artery bypass surgery with cardiopulmonary bypass. Recent Pat Inflamm Allergy Drug Discov 2009;3:214-20.
18. Kats S, Brands R, Hamad MA, Seinen W, Scharnhorst V, Wulkan RW, et al. Prophylactic treatment with alkaline phosphatase in cardiac surgery induces endogenous alkaline phosphatase release. Int J Artif Organs 2012;35:144-51.
19. Kim JS, Jobin C. The flavonoid luteolin prevents lipopolysaccharide- induced NF-kappaB signalling and gene expression by blocking IkappaB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells. Immunology 2005;115: 375-87. (Pubitemid 40896036)
20. Kim JM, Kang HW, Cha MY, Yoo D, Kim N, Kim IK, et al. Novel guggulsterone derivative GG-52 inhibits NF-kappaB signaling in intestinal epithelial cells and attenuates acute murine colitis. Lab Invest 2010;90:1004-15.
21. Koh SJ, Kim JM, Kim IK, Kim N, Jung HC, Song IS, et al. Fluoxetine inhibits NF-kappaB signaling in intestinal epithelial cells and ameliorates experimental colitis and colitis-associated colon cancer in mice. Am J Physiol Gastrointest Liver Physiol 2011;301:G9-G19.
22. Krappmann D, Wegener E, Sunami Y, Esen M, Thiel A, Mordmuller B, et al. The IκB kinase complex and NF-κB Act as master regulators of lipopolysaccharide-induced gene expression and control subordinate activation of AP-1. Mol Cell Biol 2004;24:6488-500. (Pubitemid 38891147)
23. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10- deficient mice develop chronic enterocolitis. Cell 1993;75:263-74. (Pubitemid 23320290)
24. Lalles JP. Intestinal alkaline phosphatase: multiple biological roles in maintenance of intestinal homeostasis and modulation by diet. Nutr Rev 2010;68:323-32.
25. Lee C, Chun J, Hwang SW, Kang SJ, Im JP, Kim JS. Enalapril inhibits nuclear factor-κB signaling in intestinal epithelial cells and peritoneal macrophages and attenuates experimental colitis in mice. Life Sci 2014;95:29-39.
26. Liang Y, Zhou Y, Shen P. NF-kappaB and its regulation on the immune system. Cell Mol Immunol 2004;1:343-50.
27. Lukas M, Drastich P, Konecny M, Gionchetti P, Urban O, Cantoni F, et al. Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis. Inflamm Bowel Dis 2010;16:1180-6.
28. Martinez-Moya P, Ortega-Gonzalez M, Gonzalez R, Anzola A, Ocon B, Hernandez-Chirlaque C, et al. Exogenous alkaline phosphatase treatment complements endogenous enzyme protection in colonic inflammation and reduces bacterial translocation in rats. Pharmacol Res 2012;66:144-53.
29. Mizoguchi A. Animal models of inflammatory bowel disease. Prog Mol Biol Transl Sci 2012;105:263-320.
30. Nam SY, Kim JS, Kim JM, Lee JY, Kim N, Jung HC, et al. DA-6034, a derivative of flavonoid, prevents and ameliorates dextran sulfate sodium-induced colitis and inhibits colon carcinogenesis. Exp Biol Med (Maywood) 2008;233:180-91. (Pubitemid 351231550)
31. Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-kappaB signaling pathways. Nat Immunol 2011;12:695-708.
32. Poelstra K, Bakker WW, Klok PA, Hardonk MJ, Meijer DK. A physiologic function for alkaline phosphatase: endotoxin detoxification. Lab Invest 1997;76:319-27. (Pubitemid 27157340)
33. Ramasamy S, Nguyen DD, Eston MA, Alam SN, Moss AK, Ebrahimi F, et al. Intestinal alkaline phosphatase has beneficial effects in mouse models of chronic colitis. Inflamm Bowel Dis 2011;17:532-42.
34. Rentea RM, Liedel JL, Fredrich K, Pritchard Jr K, Oldham KT, Simpson PM, et al. Enteral intestinal alkaline phosphatase administration in newborns decreases iNOS expression in a neonatal necrotizing enterocolitis rat model. J Pediatr Surg 2013;48:124-8.
35. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 1998;66:5224-31. (Pubitemid 29044613)
36. Souza DG, Vieira AT, Soares AC, Pinho V, Nicoli JR, Vieira LQ, et al. The essential role of the intestinal microbiota in facilitating acute inflammatory responses. J Immunol 2004;173:4137-46. (Pubitemid 39280779)
37. Stallmach A, Hagel S, Bruns T. Adverse effects of biologics used for treating IBD. Best Pract Res Clin Gastroenterol 2010;24:167-82.
38. Sueyoshi R, Ignatoski KM, Daignault S, Okawada M, Teitelbaum DH. Angiotensin converting enzyme-inhibitor reduces colitis severity in an IL-10 knockout model. Dig Dis Sci 2013;58:3165-77.
39. Tuin A, Poelstra K, de Jager-Krikken A, Bok L, Raaben W, Velders MP, et al. Role of alkaline phosphatase in colitis in man and rats. Gut 2009;58:379-87.
40. Viatour P, Merville MP, Bours V, Chariot A. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 2005;30: 43-52. (Pubitemid 40093740)
41. Yoshino T, Nakase H, Honzawa Y, Matsumura K, Yamamoto S, Takeda Y, et al. Immuno-suppressive effects of tacrolimus on macrophages ameliorate experimental colitis. Inflamm Bowel Dis 2010;16:2022-33.